Want the opportunity to work at the forefront of RT #clinicaltrials? We are recruiting! RTTQA Band 7 Clinical Scientist. This is a 1-year post, renewable subject to funding. Information can be found here: jobs.nhs.uk/candidate/joba… #medphys #rtqa

Deadline Monday 15th April, don’t miss out!

Julian Phillips shows mid-treatment scans (week 3) are an integral procedure in #IMPT for oropharyngeal Ca. Results from #RTQA for the TORPEdO IMRT v IMPT trial. #ESTRO24 Cancer Research UK , ICR-CTSU , David Thomson , National Institute for Health and Care Research

Kostas Rizos presents the +ve impact of #RTQA on protocol compliance for the PATHOS H&N trial. Although further streamlining may be possible for planning, prospective review remains essential for outlining #ESTRO24 Liverpool Head & Neck Centre CTRCardiffUni Velindre Cancer Centre Cancer Research UK National Institute for Health and Care Research

Debra Howard shows SIB planning to 62Gy for patients w/ early rectal Ca in the APHRODITE trial is feasible in a multi-centre setting, w/ protocol optimal constraints being achievable & plans comparable to the standard arm #ESTRO24 Leeds CTRU , National Institute for Health and Care Research

Following high protocol compliance in on-trial #RTQA for the ATNEC breast Ca trial, @zohalnabi suggests a less intensive retrospective review schedule can be safely implemented to monitor future compliance #ESTRO24 Patty Diez Hes 💙 , Warwick CTU , Amit Goyal , National Institute for Health and Care Research

Dose planning results from our The APHRODITE trial trial presented by Debra Howard RTTQA 😊 The trial use a novel mesorectal volume with SIB, implemented in a multicentre setting. Luckily, that’s been feasible, with almost identical OAR doses in the two arms #ESTRO24 #radonc

As always, super work by the whole RTTQA team - we’re very lucky to have their support! They are completely integral to the development and delivery of innovative radiotherapy trials in the UK #radonc #medphys

Inspiring lecture from the one and only Prof Anthony Chalmers at #ESTRO24 as he receives the Interdisciplinary Award in a packed Clyde lecture theatre in his beloved Glasgow!

Incredibly proud that our very own Liz Miles has been awarded the ESTRO 2025 Interdisciplinary Award. First ever #RTT. Congratulations Liz, richly deserved!!! #ESTRO24

Excited to work with ICR-CTSU on SOPRANO. #RTQA is underway to get centres accredited, ready for recruitment. #ClinicalTrials

Our 2024 participant newsletter is now here! Paper copies will be delivered to all UK participants shortly! Huge thanks as always to our participants, site staff, collaborators and supporters for your ongoing contributions. ICPV RTTQA SHORE-C & many more!

Great news! Proud to have supported this trial. Congratulations!

Fantastic trial of intra-tumoral injection of hydrogen peroxide during RT (releasing O2 around the tumour) with an exciting range of correlative clinical pre-clinical bio studies The ICR The Royal Marsden NHS Foundation Trust ICR-CTSU, led by Navita Somaiah. Look forward to the final results.

On World Head and Neck Cancer Day, PATHOS aims to reduce treatment intensity for HPV-positive oropharyngeal cancer. blogs.cardiff.ac.uk/centre-for-tri… 🔬 Health and Care Research Wales CU BLS Research UKCRC CTU Network Science and Innovation at Cancer Research UK Cardiff University School of Medicine Liverpool Head & Neck Centre Velindre Cancer Centre Terry M Jones Cancer Research UK RTTQA

Introducing #oART? Implementing a novel #IGRT QA program for the RAIDER trial of adaptive RT for bladder Ca resulted in an ⬆️ accuracy of 16%, with an overall concordance rate of 83%. This highlights the vital role of #RTQA in advanced RT techniques doi.org/10.1016/j.rado…

The IMRiS #trial of #IMRT in limb soft tissue #sarcoma reports low incidence of grade >=2 subcutaneous fibrosis. Proud to have contributed to this study. ⁦Beatrice Seddon⁩ ⁦Rita Simoes (She/Her)⁩ ⁦Aisha Miah 💙⁩ ⁦Science and Innovation at Cancer Research UK⁩ ⁦UCL⁩ redjournal.org/article/S0360-…

Likewise, delighted to have been a part of the set up and TMG for this important trial in #Radiotherapy for soft tissue #sarcoma. A real MDT approach.

Results of the quality assurance programme for image guided #Radiotherapy in the RAIDER trial were published in Radiotherapy and Oncology last week.

During the trial there were ongoing central reviews by RTTQA of the plan selections for the two adaptive tumour focussed groups to assess compliance. This quality assurance programme also included feedback to the site staff and additional training and guidance.